| Autor: |
Jha, Pallavi, Ambwani, Sneha, Singh, Surjit, Bhardwaj, Pankaj, Babu Varthya, Shobhan, Charan, Jaykaran |
| Předmět: |
|
| Zdroj: |
Journal of Pharmacology & Pharmacotherapeutics; Mar2022, Vol. 13 Issue 1, p92-94, 3p |
| Abstrakt: |
In contrary to the WHO method of doing such studies where information about only 30 drugs is asked to ascertain the availability of essential medicines, we asked for all drugs and that too from both the lists which is the strength of this study. World Health Organization (WHO) defines essential drugs or medicines as "those drugs that satisfy the healthcare needs of majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford."[1] Since 1975, the WHO has taken over its role on the essential drugs, which was initially a mere concept to a well-established policy.[2] In the year 1977, the WHO decided to make this concept more concrete, and thus prepared and published a model list of essential drugs which had around 200 drugs including the vaccines.[3] The WHO model of the essential medicine list (EML) thus came into force in 1977 and is being updated every two years since then.[4] The current version of the list is in its 21st edition, and the essential medicine list for children is in its seventh edition which was last updated in the month of June in the year 2019.[5] In the case of India, the first EML was published in 1996.[3] The latest list was published in 2015 with 376 drugs.[6] Many states also have their respective EML. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
